UK begins world-first alternate dosing covid-19 vaccine trial
The 13-month study will monitor the impact of the different dosing regimens on patients’ immune responses
(REUTERS)
Aditi Khanna
, PTI
The study, backed by 7 million pound of government funding, will determine the effects of using different vaccines for the first and second dose
Share Via
Read Full Story
LONDON :
Health chiefs in the UK on Thursday began what they have described as a world-first clinical trial of patients who will receive different COVID-19 vaccines for their first or second dose, to detect its impact on immunity against coronavirus.
The study, backed by 7 million pound of government funding, will determine the effects of using different vaccines for the first and second dose – for example, using Oxford University/AstraZeneca’s vaccine for the first dose, followed by Pfizer/BioNTech’s vaccine for the second.